INVO Bioscience - INVO Company Value to Revenue Ratio

Public company logo of INVO Bio (INVO)

The EV/Sales trend demonstrates the impact of the innovative INVOcell system and biomechanics developments on the market value of INVO Bioscience, Inc. (INVO). The current value of this metric is . An environmental development vector and the digitalization of services support the brand's social image. However, the small scale of operations complicates the struggle for market share against large reproductive center networks, creating risks for investors.

INVO INVO Bioscience: EV/Sales Multiple in the range 07/04/2022 - 11/20/2026

INVO (invobioscience.com): analytical breakdowns and indicator data

Fundamental valuation:INVO Bioscience Inc. INVO
Mass-produced product of INVO Bioscience, Inc.

The market views INVO Bioscience, Inc. (INVO) as a high-risk asset, where the EV-to-revenue trend reflects the business value net of debt relative to sales volumes. This indicator filters out speculative noise, revealing the extent to which the slow adoption of oocyte maturation systems and high distribution costs are hindering the company's capitalization within this security category.

Competitor analysis for INVO Bioscience, Inc.

BSX (Boston Scientific) - Company Value to Revenue Ratio|EW: EV/Sales Multiple|RMD - Total Company Value-to-Revenue Ratio|PODD (Insulet Inc.) - EV/Sales Multiple|Company Value to Revenue Zimmer Biomet Corp (ZBH)|EV/Sales Multiple COO|Company Value to Revenue Align Technology, Inc. ALGN|EV/Sales Multiple GMED (globusmedical.com)|EV/Sales Multiple TransMedics Group, Inc. TMDX|ATEC - Enterprise Value-to-Revenue Ratio|AORT: Enterprise Value-to-Revenue Ratio|ENOV (Enovis Corporation) - Company Value to Revenue|Integra LifeSciences - Business Value to Revenue|ESTA (Establishment Labs Inc) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple Beta Bionics, Inc. BBNX|Enterprise Value-to-Revenue Ratio IRADIMED Corp (IRMD)|Embecta Corp. (EMBC) - Enterprise Value-to-Sales Ratio|Tandem Corp - Company Value to Revenue|EV/Sales Multiple AxoGen, Inc. AXGN|SI-BONE Inc - EV/Sales Multiple|Total Company Value-to-Revenue Ratio Orthofix Medical OFIX|Bioventus Global (BVS) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume KIDS (OrthoPediatrics Inc.)|Enterprise Value-to-Revenue Ratio treace.com|Company Value to Revenue Strata Critical Medical Inc (SRTA)|EV/Sales Multiple CARL|RXST - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio clearpointneuro.com CLPT|STXS: Company Value to Revenue Ratio|STIM: Company Value to Revenue|sightsciences.com - Enterprise Value-to-Revenue Coefficient|Orchestra BioMed Inc. (OBIO) - Enterprise Value-to-Revenue Ratio|Anika (ANIK) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio InspireMD, Inc.|zhjmedical.com (ZJYL) - Total Company Value-to-Revenue Ratio|Company Value to Revenue VANI (Vivani Medical)|EV/Sales Multiple Xtant Medical Holdings, Inc. (XTNT)|Enterprise Value-to-Revenue Ratio NeuroOne Medical Technologies Corporation NMTC|EV/Sales Multiple Modular Medical MODD|MYO: Company Value to Revenue|Enterprise Value-to-Revenue Multiple Envoy Medical, Inc.|VVOS (Vivos Therapeutics) - Company Value to Revenue|Company Value to Revenue Ratio NVNO|Company Value to Revenue SINT|Company Value to Revenue Tenon Medical (TNON)|Enterprise Value-to-Revenue Ratio ReWalk Robotics Ltd (LFWD)|Total Company Value-to-Revenue Ratio Autonomix|EV/Sales Multiple IVF (invobioscience.com)|bonebiologics.com - Enterprise Value-to-Revenue Ratio|AXNX - Enterprise Value-to-Revenue Ratio|BIOL (BIOLASE) - Company Value to Revenue Ratio|Dynatronics Corporation (DYNT) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue Ratio FNA